TrialInternational journal of radiation oncology, biology, physics2025

Concerning Safety and Efficacy of Concurrent and Consolidative Durvalumab With Thoracic Radiation Therapy in PDL1-Unselected Stage III Non-Small Cell Lung Cancer: Brief Report.

Yuanyuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.